Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Chairman operating in the Medical Device space. If you think a Chairman is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Charles Spicer
Chairman of Creo Medical
Charles is an experienced director of and adviser to public and private companies primarily in the med-tech sector. He is non-executive chairman of PuriCore plc, IXICO plc and 11 Health. He is a chair of the UK Department of Health’s Invention for Innovation (i4i) Funding Panel. Until recently he was a director of Aircraft Medical (acquired by Medtronic Inc. in December 2015) and Stanmore Implants (acquired by Stryker Inc., April 2016). He was previously chief executive of MDY Healthcare plc, a strategic healthcare investor and, prior to that, head of healthcare corporate finance at both Numis Securities and Nomura International.
Follow Charles Spicer:
About City & Guilds Group, Creo Medical, Ixico, KwickScreen, MJ Hudson: Creo Medical is a developer of electrosurgical devices.
Chas Taylor
Chief Executive Officer & Chairman of Respiratory Motion
Mr. Taylor has over 30 years of experience in the medical technology industry. Recently he was the CEO of Veryan Medical, a Co-founder and Director of Novate Medical, and a Director of BrightWater Medical. All three of these companies were acquired in the last three years. Previously, Mr. Taylor was the Co-founder of MedNova, which was acquired by Abbott Laboratories. Prior to founding and leading these companies, he had a long career with Bard Cardiovascular and General Surgical products where he had roles of increasing responsibility in general management and international sales and marketing.
Follow Chas Taylor:
About : Respiratory Motion ExSpiron is FDA and CE Mark cleared and non-invasively measures minute ventilation, the fundamental unit of breathing.
David Tuch
Founder & Executive Chairman of Lightpoint Medical
David Tuch is the Founder and CEO of Lightpoint Medical. He has more than a decade of experience in the medical imaging and pharmaceutical sectors. Previously, he was Head of Research Alliances at GE Healthcare and Head of Clinical Imaging at Novartis. Before joining industry, Dr. Tuch served on the faculty of Harvard Medical School and Massachusetts General Hospital, Department of Radiology. He is currently an Honorary Senior Lecturer in the Imperial College, Department of Bioengineering. Dr. Tuch holds a PhD from MIT and Harvard Medical School, a BA from the University of Chicago, and has completed executive education at INSEAD.
Follow David Tuch:
About Lightpoint Medical, Lucida Medical: Lightpoint Medical, a medical device company, develops intra-operative imaging technology that can detect cancer during surgery.
Chris Hand
Chairman of Abingdon Health
Follow Chris Hand:
About Molecular Vision: Abingdon Health is an innovative technology-led company focused on providing rapid and near-patient medical diagnostic testing solutions.
Quentin Pankhurst
Chairman of MediSieve
Quentin is a world expert in magnetic nanoparticles, and an academic innovator with direct experience in the medical technology sector. In 2007, he founded Endomagnetics to commercialise a device for sentinel node detection in breast cancer, serving the company as CEO until 2010 and as a board member until 2014. He played a key role in CE marking the device, which has treated more than 3,500 patients in 15 countries. A physicist by training, Quentin is the Director of the Healthcare Biomagnetics Laboratory at UCL, where he runs programmes in bio- and nanomagnetism aimed at making practicle advances in the use of magnetic nanoparticles in healthcare. He is a champion of translational R&D, for which he established the UCL Institute of Biomedical Engineering. The objective of the IBME is to bring together UCL’s excellence in academic and clinical R&D – around a thousand staff, fellows, nurses and students in 35 different centres, departments and institutes – to create the world’s best research centre for biomedical engineering.
Follow Quentin Pankhurst:
About Endomag, University College London (UCL): MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Dr Bruce Roser
Chairman & CSO of Stablepharma Ltd
Dr Bruce Roser MB BS, PhD – Chairman & Founder. Discovered the preservation properties of the resurrection plant. A distinguished international career in biomedical research with 108 refereed papers and 49 patents.
Follow Dr Bruce Roser:
About Stablepharma Ltd: An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines
Jonathan Glenn
Chairman of Tissue Regenix
Follow Jonathan Glenn:
About Tissue Regenix: Tissue Regenix commercializes innovative technologies in regenerative medicine.
Hugh Lloyd-Jukes
CEO and Chairman of Oxehealth
Hugh Lloyd-Jukes is the CEO and Chairman at Oxehealth.
Follow Hugh Lloyd-Jukes:
About Oxehealth: SaaS workflow solution gives carers and custodians more time for hands on care where and when it’s needed most.
Maureen Coleman
Executive Chairman of CN Bio Innovations
Mrs Coleman has amassed over 20 years’ experience within the pharmaceutical industry, latterly as VP Global Strategy Development for GlaxoSmithKline. Since 2007 she has been working with a number of investor-backed companies including as founding Chief Executive of NovaThera, a regenerative medicine spin-out from Imperial College London, and as Director, Chairman and Chief Executive of life science spin-out companies from Oxford, Kings College, and Brunel Universities. Mrs Coleman is currently Chairman of Parafricta Ltd, a wound care materials business, and is a Director of MedInnovate Ltd, a technology consultancy spanning the healthcare industry. Mrs Coleman joined CN Bio Innovations in 2009 and became Chairman in 2011. She brings a wealth of sector relevant knowledge to the CNBIO team and experienced leadership in developing early stage life science businesses.
Follow Maureen Coleman:
About CN Bio Innovations, CN Bio Innovations, Parafricta: CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Prof Sir Michael Brady FRS FREng FMedSci
Chairman of Optellum
Follow Prof Sir Michael Brady FRS FREng FMedSci:
About Optellum: Optellum develops an imaging biomarker for smart lung cancer detection.
Christopher Getley
Chairman of AgPlus diagnostics
Over 25 years of experience at senior level in financial services including terms as a Director at Morgan Grenfell (subsequently Deutsche Bank) Asset Management and Partner at Cazenove & Co.Mr Getley has also been CEO of corporate advisory boutique Smith’s and corporate broker Westhouse Securities.He was responsible for the buyout of AgPlus Diagnostics from Serco Group plc in July 2015.He received a Combined Honours degree in Chemistry and Law from Exeter University in 1986.
Follow Christopher Getley:
About : Ag+ has been to deliver a rapid diagnostic platform technology .
Trevor Smith
Chairman of Bedfont Scientific
Follow Trevor Smith:
About Bedfont Scientific: Bedfont Scientific specializes in the design and manufacture of exhaled breath and gas monitoring instruments.
